chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Feeling hot, Headache
Clinical narrative: Extreme fatigue; Headache; Loss of appetite; Feeling hot (no fever); This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 18:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety disorder. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included prescribed anxiety medication (unspecified); for anxiety from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Feb2021 at 09:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 04Mar2021 at 11:00, the patient experienced extreme fatigue and headache for 3 days following vaccine, loss of appetite and feeling hot (no fever). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events extreme fatigue and headache was recovered on 07Mar2021 however the events loss of appetite and feeling hot (no fever) was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Nausea, Pain in extremity
Clinical narrative: Nausea; Tiredness, feeling drained; Swollen lymph nodes under right armpit and in neck; Headache; Sore arm; This is a spontaneous report from a contactable other healthcare professional, the patient. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 05Mar2021 at 12:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol/levonorgestrel (AMETHIA LO) and fexofenadine hydrochloride (ALLEGRA) for unknown indications from unknown dates and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN), sulfamethoxazole/trimethoprim (SEPTRA), cefdinir (OMNICEF), vancomycin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and experienced drug allergy. On 05Mar2021 at 13:30, one-hour post vaccination the patient experienced headache and sore arm. The patient experienced tiredness, felt drained and swollen lymph nodes under the right armpit and in the neck which was not sore and did not hurt. These were still present 3 days post-vaccination. On 05Mar2021 at 20:30, the patient experienced nausea after 8 hours of vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 05Mar2021, lasted approximately 4 hours. The clinical outcome of the event nausea was recovered 06Mar2021, lasted approximately 6 hours. The clinical outcome of the event sore arm was recovered on 06Mar2021 at 13:30, after the duration of 24 hours. The clinical outcome of the event tiredness, feeling drained, and swollen lymph nodes under right armpit and in neck were not recovered (also reported as recovering) at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Lethargy, Nausea
Clinical narrative: Fatigue; Lethargy; Loss of appetite; A little nauseated; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El3247) via an unspecified route of administration in the left arm on 24Feb2021 at 10:45 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. Medical history included arthritis. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included loratadine, pseudoephedrine sulfate (CLARITIN-D), indometacin (INDOMETHACIN) and meloxicam (MOBIC); all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Feb2021 at 10:45 (at the age of 69-year-old), as a single dose for COVID-19 immunisation. On 26Feb2021, the patient experienced fatigue, lethargy, loss of appetite and was a little nauseated. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events fatigue, lethargy, loss of appetite and was a little nauseated was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Myalgia, Oropharyngeal pain
Clinical narrative: Hoarse and raspy voice three days after vaccine; sore throat for only a few hours after voice changeoccurred.; Soreness in the injected arm muscle the evening ofthe injection; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 06Mar2021 at 09:30 as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN) and ascorbic acid, biotin, calcium, calcium phosphate dibasic, chromic chloride, cupric oxide, cyanocobalamin, ferrous fumarate, folic acid, magnesium oxide, manganese sulfate, nickel sulfate, nicotinamide, pantothenic acid, phytomenadione, potassium chloride, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, sodium metasilicate, sodium molybdate, sodium selenate, thiamine mononitrate, tocopheryl acetate, vitamin d not otherwise specified, zinc oxide (CENTRUM SILVER) both for an unknown indication from an unknown dates and unknown if ongoing. On 09Mar2021 at 10:00, the patient experienced  hoarse and raspy voice three days after vaccine, sore throat for only a few hours after voice change occurred. The patient felt fine; temperature was normal. The patient received vaccination in the morning and got soreness in the injected arm muscle the same evening of the injection. Fourth day after vaccine voice was still hoarse and raspy, no fever, felt fine. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hoarse and raspy voice, sore throat and muscle soreness at injected arm was not recovered at the time of this report  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness around injection area/ unable to move left arm freely; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 24Feb2021 at 09:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to jackfruit and shrimp from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 19:00, the patient experienced soreness around injection area and unable to move left arm freely. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness around injection area and unable to move left arm freely was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling cold
Clinical narrative: Felt cold; Low back was achy; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 13:45 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis and HTN (hypertension). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included apixaban (ELIQUIS), metoprolol (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), cetirizine hydrochloride (ZYRTEC) and MVI (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Feb2021 at 14:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. The patient previously received celecoxib (CELEBREX) and famciclovir (FAMVIR), for unknown indication from an unknown date and experienced drug allergy. On 10Mar2021 at 16:00, 24 hrs after 2nd injection, the patient felt cold and her low back was achy. Took paracetamol (TYLENOL) and it went away in a few hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported events which included treatment with paracetamol (TYLENOL). The clinical outcome of the felt cold and her low back was achy was resolved on an unknown date in Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness at injection site 2 weeks after vaccination about 1 3/4"; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Feb2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The medical history included osteopenia and low thyroid. It was unknown whether the patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine sodium (THYROXINE), omeprazole (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL); all from unknown dates for unknown indications and unknown if ongoing. On 11Mar2021, two weeks after vaccination the patient experienced redness at injection site about 1 3/4. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event redness at injection site was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oropharyngeal discomfort, Oropharyngeal pain, Tonsillitis
Clinical narrative: Adjacent gland in "my" neck has remained tender and a bit swollen; throat soreness is on the same side of "my" body as myshot, and the throat tenderness feels more like a strained muscle when "I" swallow.; sharp discomfort in "my" throat; "I" developed a Sore left tonsil during the night that persisted through the day; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 01Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included inflammatory arthritis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included SYNTHROID, BUPROPION, FOSAMAX, and REMICADE, all for an unspecified indication from an unknown dates and unknown if ongoing. All was well until a week after the shot and then on 08Mar2021 at 03:00, the patient developed a sore left tonsil during the night that persisted through the day, salt water gargling helped the patient with the more sharp discomfort in her throat, but the adjacent gland in her neck had remained tender and a bit swollen. The tender gland or throat soreness was on the same side of her body as her shot and the throat tenderness felt more like a strained muscle when she swallowed. The tenderness continued till the fourth day after the event occurred even on the day of report. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event adjacent gland in neck has remained tender and a bit swollen, throat soreness or tenderness, discomfort in throat and sore left tonsil was not recovered at the time of this report.   No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperaesthesia
Clinical narrative: Hypersensitive tactile sensation. Any part of my body that was in contact with anything felt like it wasn't part of my body.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 07:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), diabetes and obesity. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021 at 20:00, the patient experienced hypersensitive tactile sensation. Any part of patient body that was in contact with anything felt like it was not part of patient body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hypersensitive tactile sensation. Any part of patient body that was in contact with anything felt like it was not part of patient body was recovered on unspecified date of Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain
Clinical narrative: "I" feel achy and bad, almost like when "I" caught Covid-19 about 7 months ago.; "I" feel achy and bad, almost like when "I" caught Covid-19 about 7 months ago.; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Mar2021 at 11:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date in 2020, about seven months before the time of report and had shrimp allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 09:00, the patient felt achy and bad, almost like when he caught COVID-19 about 7 months prior to this report. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt achy and bad, almost like when he caught COVID-19 about 7 months prior to the report was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Muscle tightness, Pain in extremity
Clinical narrative: Shivering; Muscles were tensed; Both forearms and hands ached; Great difficulty sleeping; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 12:45 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Feb2021 at 11:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 10Mar2021 at 12:15, at night the patient began shivering and all her muscles were tensed. This shivering lasted at least two hours. Both forearms and hands ached and the patient had great difficulty sleeping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shivering, muscles were tensed, forearms and hands ached, great difficulty sleeping was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: prominent lymph node in leftaxillary area, the same arm received vaccination.; This is a spontaneous report from a contactable other health care professional, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 23Feb2021, at 09:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included blepharitis and penicillin allergy. Concomitant medications included levonorgestrel (SKYLA), ciclosporin (RESTASIS), polyvinyl alcohol (REFRESH), OCCOSOFT PLUS, calcium carbonate/magnesium carbonate (TUMS) and calcium carbonate/magnesium hydroxide (MYLANTA); all for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 10:30, the patient experienced prominent lymph node in left axillary area. It was reported that she had a breast magnetic resonance imaging (MRI) on 09Mar2021 as per regular check-up and her doctor (via a call on 11Mar2021) noted a prominent lymph node in her left axillary area, the same arm she received her vaccination. The doctor thought it might be vaccine related. She was advised to have a follow-up ultrasound/mammogram in about six weeks. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event prominent lymph node in left axillary area was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, SARS-CoV-2 test
Clinical narrative: 24 post-vaccination patient began feeling severe stomach discomfort followed by 5 days of severe diarrhea that warranted an urgent care visit.; 24 post-vaccination patient began feeling severe stomach discomfort followed by 5 days of severe diarrhea that warranted an urgent care visit.; This is a spontaneous report from a contactable pharmacist. A 69-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el9267) via intramuscular route of administration in the left arm on 18Feb2021 at 10:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included anticoagulant therapy. The patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021 at 19:00, 24 post-vaccination the patient began feeling severe stomach discomfort followed by 5 days of severe diarrhea that warranted an urgent care visit. It was reported that the patient refused second vaccination in fear of similar reaction going forward. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events and included treatment with fluids. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event 24 post-vaccination patient began feeling severe stomach discomfort followed by 5 days of severe diarrhea that warranted an urgent care visit was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: I woke up extremely fatigued; I woke up extremely fatigued and achy, just like I did when I had the actual virus back in December; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 08:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included peripheral arterial disease, blood pressure high and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), metoprolol (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 10Mar2021 at 04:00, the day following the vaccine, the patient woke up extremely fatigued and achy just like how the patient had the actual virus back in December. The patient stayed home from work. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event woke up extremely fatigued and achy was resolved on an unspecified date in Mar2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Several hours later had real pain all up the arm.; This is a spontaneous report from a contactable consumer, the patient. An 80-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 08Mar2021 at 17:15 (at the age of 80-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve insufficiency, high cholesterol, thyroid, acid reflux and known allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included several unspecified medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was reported that the patient felt a prick as the needle went in, but also had a weird feeling as if liquid was going in her arm- like a little worm. On 08Mar2021 at 20:00, several hours after vaccination, the patient experienced real pain all up the arm. Therapeutic measures were taken as a result of pain in arm which included treatment with ice pack but that did not help much and the patient took 2 acetaminophen (MANUFACTURER UNKNOWN) 500 mg tablets that helped a little and next day was much better. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in arm was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Severe vertigo; This is a spontaneous report from a non-contactable consumer, the patient. A 79-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration on the right arm on 02Mar2021 at 14:45 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (COMIRNATY, Lot number: EN6201) via an unspecified route of administration on the right arm on 09Feb2021 at 02:15 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. On 05Mar2021 at 07:00, the patient experienced severe vertigo. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included scheduled therapist visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe vertigo was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Two swollen lymph nodes above left clavicle.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 08:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluconazole (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously took vancomycin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 05Mar2021, the patient experienced two swollen lymph nodes above the left clavicle. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event two swollen lymph nodes above left clavicle was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall
Clinical narrative: That night, "I" went to bed and woke up to attend to "my" dog and when "I" opened my eyes "I" was dizzy and fell over when "I" stood up; That night, "I" went to bed and woke up to attend to "my" dog and when "I" opened my eyes "I" was dizzy and fell over when "I" stood up; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 03Mar2021 at 09:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medicines within two weeks prior to the COVID-19 vaccine. On 04Mar2021 at 02:30, the patient went to bed and woke up to attend to dog and when the patient opened her eyes, the patient was dizzy and fell over when she stood up. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy and fall were recovered with sequelae at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Around 9:30/10 p.m i started getting a lot of nausea; I started getting a lot of nausea and threw up a lot; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 05Mar2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included pericarditis and aortic aneurysm repair. The patient received unspecified medication within 2 weeks of vaccination (also reported as not enough room) from an unknown date for unknown indication and unknown if ongoing. The patient previously took doxycycline (DOXICYCLINE) and tetracycline (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 around 21:30/ 22:00, the patient started getting a lot of nausea and threw up a lot and had diarrhea. He only threw up on friday night, but since then he had constant diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, around 9:30/10 pm started getting a lot of nausea was not recovered. The clinical outcome of the event started getting a lot of nausea and threw up a lot was recovered on 05Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Observed that vision was affected / beams from headlights appeared to be significantly dim; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 09Mar2021 at 16:30 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient was allergic to sulfa and adhesives. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received glyceryl trinitrate (NITROSTAT) and experienced drug allergy. On 09Mar2021 at 18:45, later in the evening on the day of vaccination, the patient observed that his vision was affected. It was reported that, while driving he observed that the beams from the headlights appeared to be significantly dim. He attempted to verify that the headlights were in fact dim by visually inspecting them directly and found that they were not. Nevertheless, when observing the light that was thrown on the roadway, its appearance was significantly dim in appearance. The high beams threw more light but were also less bright than normal. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vision was affected was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Myalgia, Rhinorrhoea
Clinical narrative: "I" have chills; Runny nose; Light headedness; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 28Feb2021 at 14:45 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN); both from an unknown start date for an unknown indication and unknown if ongoing. The patient previously received acetylsalicylic acid (ASPIRIN) and codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration in the left arm on 07Feb2021 at 14:45 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. On 01Mar2021 at 08:00, the patient experienced chills, runny nose, light headedness and muscle pain. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, runny nose, light headedness and muscle pain were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Soreness and minor swelling under left arm starting Thursday morning, Mar 11, 2021; Soreness and minor swelling under left arm starting Thursday morning, Mar 11, 2021; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 09Mar2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis resolved with colectomy/J-pouch. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for unknown indication from an unknown date and unknown if ongoing. The patient experienced soreness and minor swelling under left arm starting thursday morning on 11Mar2021.Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness and minor swelling under left arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Pain, Pain in extremity
Clinical narrative: inner side of left arm is painful the arm pit tomy waistband.; Inner side of left arm is painful the arm pit tomy waistband.; Headache; Body pain; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW62O5) via an unspecified route of administration in the left arm on 09Mar2021 at 11:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously took axocillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 09Mar2021 at 23:00, on the first day, the patient experienced 24 hours of headache and body pain. The same symptoms had carried  on into the second day. On 11Mar2021, the patient's entire inner side of left arm was painful, the arm pit to the waistband. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events inner side of left arm painful, the arm pit pain to the waistband, headache and body pain were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Taste disorder
Clinical narrative: Metallic taste in mouth, change in taste; Metallic taste in mouth, change in taste; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 25Feb2021(at the age of 66-years-old) as a single dose for COVID-19 immunisation. The medical history were reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The  patient did not receive any medications within two weeks of vaccination. On 26Feb2021, the patient experienced metallic taste in mouth and change in taste. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste in mouth and change in taste was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Soreness around injection site (mild); Fatigue (moderate); This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 10Mar2021 at 11:30 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma and arthritis. The patient had no known allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included doxycycline (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), colecalciferol (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and unspecified vitamin; all for an unknown indication from an unknown date and unknown if ongoing. On 11Mar2021 at 08:00, the patient experienced soreness around injection site (mild) and fatigue (moderate). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events soreness around injection site (mild) and fatigue (moderate) was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dysgeusia, Headache
Clinical narrative: Metallic taste in mouth; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Mar2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and penicillin allergy and sulfa drugs . Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included verapamil hydrochloride (VERAPAMIL ER) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021, at 12:00 (also reported as 00:00) the patient experienced metallic taste in mouth, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste in mouth, headache and diarrhea was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Nausea, Vertigo
Clinical narrative: The following day of 1st vaccine, woke up severely dizzy; Vertigo; Severe headache; Nauseous; Feeling off; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 09:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), breast cancer, stent in carotid artery, coil in aneurysm. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), clopidogrel (MANUFACTURER UNKNOWN), rabeprazole (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all were from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 02Mar2021 at 08:00, the following day of 1st vaccine, the patient experienced woke up severely dizzy, vertigo, severe headache nauseous was in bed for 3 days with these symptoms and as of today still feel dizzy, headache and feeling off she did not know if she should get 2nd shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the following day of 1st vaccine woke up severely dizzy, vertigo, headache, nauseous and feeling off was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.